Patent · US Active

Immunosuppresant compounds and compositions

US7939519B2 · kind B2 · utility

10Cited by
6References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2008
Grant dateMay 10, 2011
Priority date
Expiry dateFeb 1, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.